Dr. Ziv Shulman earned his BSc in animal science at the Hebrew University of Jerusalem. He earned an MSc (2005) and PhD in immunology (2010), both with honors, at the Weizmann Institute of Science. From 2011-2015, Dr. Shulman conducted postdoctoral research at the Rockefeller University in New York City, and joined the Department of Immunology at the Weizmann Institute in August 2015.
Long lasting protection from harmful pathogens depends on the formation of high affinity neutralizing antibodies. How pathogen-specific antibodies emerge and how they evolve and improve over time are the major questions addressed by the Shulman-lab. In particular, the lab examines how communication among different immune cells types within specialized niches promote pathogen-specific immune responses. Understanding these cellular and molecular components is fundamental for design of new vaccine strategies and immunotherapy for a wide range of diseases, including various forms of cancer.
In 2015, Dr. Shulman received the Sir Charles Clore Prize for Outstanding Appointment as a Senior Scientist, a Blavatnik Award for postdoc fellows, and the Rockefeller University’s Tri-Institutional Breakout Award for Junior Investigators (awarded jointly with the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College). He was selected to receive a Human Frontier Science Program (HFSP) Career Development Award (2016), a Human Frontiers of Science Program (HFSP) fellowship (2012), and a long-term EMBO fellowship (2011). His graduate studies were recognized by the Weizmann Institute’s Feinberg Graduate School through prizes for outstanding PhD students in 2011 and for outstanding MSc students in 2006.
He is married and has two children.
« Go Back